Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial

BACKGROUND: In contrast to drug-sensitive tuberculosis, the guidelines for the treatment of multi-drug-resistant tuberculosis (MDR-TB) have a very poor evidence base; current recommendations, based on expert opinion, are that patients should be treated for a minimum of 20 months. A series of cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunn, Andrew J, Rusen, ID, Van Deun, Armand, Torrea, Gabriela, Phillips, Patrick PJ, Chiang, Chen-Yuan, Squire, S Bertel, Madan, Jason, Meredith, Sarah K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164715/
https://www.ncbi.nlm.nih.gov/pubmed/25199531
http://dx.doi.org/10.1186/1745-6215-15-353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164715/
https://www.ncbi.nlm.nih.gov/pubmed/25199531
http://dx.doi.org/10.1186/1745-6215-15-353

Ejemplares similares